← Leaderboards
Olga A Guryanova
Sloan-Kettering Inst Can Research
$2,670,428
Attributed
$2,670,428
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $343.1K · FY2013–23$500K$375K$250K$125K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
Funding mix
By agency
NIH$2,670,428 · 3
By mechanism
R01$1,715,625 · 1
R00$758,913 · 1
K99$195,890 · 1
Top collaborators
No co-investigators on record.
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Eirini Papapetrou$13,419,805
- Ross L Levine$31,715,816
- Michael Kharas$18,485,709
- Aaron D Viny$3,272,036
- Jacob Lowell Glass$1,421,573
Others in their field
Top investigators on “Stress”
- Chanza Baytop · Westat, Inc.$271,217,917
- Judith S Hochman · New York University School Of Medicine$109,572,916
- James E. Gern · University Of Wisconsin-Madison$100,351,848
- Sharon A Nachman · Johns Hopkins University$74,725,055
- Robert O Wright · Brigham And Women'S Hospital$71,259,719
- Leonardo Trasande · New York University School Of Medicine$59,472,515
Research focus
StressStem CellsSelf-RenewalPhenotypeMutantMouse ModelSamplingDna Modification MethylasesGeneticHematopoieticIn VivoLeukemiaMolecularChemotherapyMutationPathway InteractionsCancer TherapyDna MethylationGene ExpressionGenesCellsHematopoiesisIn VitroStem
Grant awards (10)
The role of DNMT3A mutations in clonal heterogeneity and evolution of hematopoiesis$343,125
R01 · FY2023 · DK · contact PI
The role of DNMT3A mutations in clonal heterogeneity and evolution of hematopoiesis$343,125
R01 · FY2022 · DK · contact PI
The role of DNMT3A mutations in clonal heterogeneity and evolution of hematopoiesis$343,125
R01 · FY2021 · DK · contact PI
The role of DNMT3A mutations in clonal heterogeneity and evolution of hematopoiesis$343,125
R01 · FY2020 · DK · contact PI
The role of DNMT3A mutations in clonal heterogeneity and evolution of hematopoiesis$343,125
R01 · FY2019 · DK · contact PI
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia$252,971
R00 · FY2018 · CA · contact PI
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia$252,971
R00 · FY2017 · CA · contact PI
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia$252,971
R00 · FY2016 · CA · contact PI
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia$97,945
K99 · FY2014 · CA · contact PI
Biologic and therapeutic relevance of DNMT3A mutations in acute myeloid leukemia$97,945
K99 · FY2013 · CA · contact PI